We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Destiny Pharma Plc | LSE:DEST | London | Ordinary Share | GB00BDHSP575 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.00 | 2.50 | 3.50 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
10/4/2024 12:09 | Certainly does if Steriwave has the same kill % as XF73 Which it appears too, | john henry | |
10/4/2024 11:35 | Thanks martinrai1950. Looks bad news for XF73. | jias | |
10/4/2024 07:30 | Spot on Henley imho over the next few years the UK will lose a complete sector in Biotech/Tech. | john henry | |
10/4/2024 06:43 | E-Therapeutics the next company going private. Reading their RNS tells you everything that is wrong with the AIM market. Destiny next? | henley2 | |
09/4/2024 15:03 | And what of Sir Nigel thus far? | carlisle44 | |
09/4/2024 09:29 | More interested in announcement of deals they are negotiating. New CEO was praised but so far achieved nothing. Except crashing share price.IMHO | mam fach | |
08/4/2024 16:22 | Hopefully someone will ask at the Investor Meet whether or not there is a chance of this going private???? With REDX in mind! | wh1spa | |
05/4/2024 18:09 | Boney i guess that explains how wrong you were with AGL | john henry | |
05/4/2024 15:48 | Unfortunately as expected heading lower now as the cash gets used and no development or positive news coming. To think this was supposedly a bargain at 70p not long ago. Shows how wrong people can be and that timing is vital whje investing. | bones698 | |
05/4/2024 08:57 | TT you are such a clown stop talking to yourself you are boring | brooko19 | |
04/4/2024 21:55 | Brooko et al should be ashamed of themselves. Bigging this stock up, and putting others opinions down, disgusting behaviour | ttlance | |
02/4/2024 12:57 | Looking forward to finding out the details of the LTIP for CT et al in the coming FY23 results. | wh1spa | |
01/4/2024 21:45 | Here's hoping they are in advanced discussions and as it's almost in the bag they are focusing on XF D? | wh1spa | |
01/4/2024 07:40 | Whispa, why would they want to provide an update to the market saying they are struggling finding a partner? Though realistically this is the case and if they were to provide such an update then the share price will certainly drop into the 10’s on such an announcement. | ttlance | |
31/3/2024 14:41 | Are we to conclude - from the share price action over recent months - that finding a partner for XF nasal is proving difficult/impossible | wh1spa | |
28/3/2024 18:50 | Something smells very fishy, with the time it has taken to not conclude a partnership deal the more likelihood that if there is one it will be a poor deal. Coupled with the fact that there is now no milestone payment for M3. Funds lasting until Feb 2025 meaning fundraise in August this year. I predict the market makers will manipulate this where we see a rise over the coming months with an announcement of a fund raise being at 25p. | ttlance | |
28/3/2024 15:58 | Another hope share same as AGL . Burning so much money without any income . Shareholders money keeping this afloat . 99% fail | aimscam1 | |
28/3/2024 11:47 | Dest have enough cash until Q2 2025. My guess is that they would conclude the JV before raising further funds. Saying that funding requirements will depend on the upfront cash payment from the JV. | john henry | |
28/3/2024 11:45 | The lack of communication from Management after a 70% fall in the share price since mid December is astounding. I had hoped the new CEO would be dynamic but quite the opposite given this downtrend. | adorling | |
28/3/2024 11:42 | TBH i can see many young Biotech stocks going private, Unfortunately UK investors will not see the growth. | john henry | |
28/3/2024 11:42 | Bought little. Anything less than 25 is good risk reward for 2-3 years. always wanted to buy sub 25P. I missed it when it was 28p few months back and reached all the way to close to 80p. Best time to add now when fear is here. Only concern is Fund raise which will come and may slam price down further but in a grand scheme of picture this is good level to buy | eva_1989 | |
28/3/2024 11:28 | Dest has decided to go private and are following in c4xd footsteps | beatme1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions